Stratified medicine approach for managing angina without obstructive coronary artery disease
Official title: International Study of Coronary Microvascular Angina (iCorMicA): a Randomised, Controlled, Multicentre Trial and Registry
Run by NHS Greater Glasgow and Clyde · NCT04674449 · Data updated 2026-11-12
This study is testing if a personalized treatment plan based on a special heart test can help people with angina who don’t have blocked arteries feel better and improve their health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | NHS Greater Glasgow and Clyde Academic / other |
| Locations | 39 sites (Cork and 38 other locations) |
| Status | Recruiting |
| Started | December 30, 2020 |
| Main results expected | June 30, 2026 |
| Study ends | December 31, 2030 |
| Registry record updated | April 9, 2026 |
| Trial ID | NCT04674449 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are scheduled for invasive coronary angiography and exhibit symptoms of angina.
✕Probably not a fit
Patients with obstructive coronary artery disease or those undergoing angiography for non-coronary reasons may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The iCorMicA study is a multicentre, prospective, randomised, double-blind, sham-controlled trial aimed at improving the management of patients with angina who do not have obstructive coronary artery disease. It evaluates whether tailored medical therapy, guided by an interventional diagnostic procedure during invasive coronary angiography, can enhance patient symptoms, wellbeing, and clinical outcomes. The study builds on previous findings that suggest stratified medicine may significantly benefit patients with microvascular angina and related conditions. Participants will be randomly assigned to receive either the results of the diagnostic procedure or a sham intervention.
Why it matters
Potential benefit: If successful, this study could lead to improved symptom management and quality of life for patients with microvascular angina.
How similar studies have gone: Previous studies, such as the CorMicA pilot, have shown promising results for similar stratified medicine approaches in managing ischaemic heart disease.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years. 2. A clinical plan for invasive coronary angiography. 3. Symptoms of angina (typical or atypical) according to the Rose- and/or Seattle Angina questionnaires. 4. Able to comply with study procedures. 5. Able to provide informed consent. Exclusion Criteria: 1. A non-coronary primary indication for invasive angiography (e.g. valve disease, heart failure). 2. History of coronary artery bypass surgery. 3. Presence of obstructive disease evident in a main coronary artery (diameter \>2.5 mm), i.e. a coronary stenosis \>50% and/or a fractional flow reserve (FFR) ≤0.80\*. 4. Logistical reason\*. \*These patients will enter a follow-up registry.
Where it's running
-
Radboud University Medical Centre
Nijmegen, Netherlands Recruiting -
5th Military Hospital
Krakow, Poland Recruiting -
Golden Jubilee National Hospital
Clydebank, Scotland, United Kingdom Recruiting -
William Harvey Hospital
Ashford, United Kingdom Recruiting -
Bedford Hospital NHS Trust
Bedford, United Kingdom Recruiting -
Royal Victoria Hospital
Belfast, United Kingdom Recruiting
Show 33 more locations
-
Birmingham Heartlands Hospital
Birmingham, United Kingdom Recruiting -
Royal Blackburn Teaching Hospital
Blackburn, United Kingdom Recruiting -
Victoria Hospital
Blackpool, United Kingdom Recruiting -
Glan Clwyd Hospital
Bodelwyddan, United Kingdom Recruiting -
University Hospital of Wales
Cardiff, United Kingdom Recruiting -
St Peter's Hospital NHS Foundation Trust
Chertsey, United Kingdom Recruiting -
University Hospitals Coventry & Warwickshire NHS Trust
Coventry, United Kingdom Recruiting -
University Hospital Hairmyres
East Kilbride, United Kingdom Recruiting -
Raigmore Hospital
Inverness, United Kingdom Recruiting -
Leeds Teaching Hospital NHS Trust
Leeds, United Kingdom Recruiting -
Liverpool Heart and Chest Hospital
Liverpool, United Kingdom Recruiting -
Royal Free Hospital
London, United Kingdom Recruiting -
King's College Hospital
London, United Kingdom Recruiting -
Northwick Park Hospital
London, United Kingdom Recruiting -
The Newcastle upon Tyne Hospitals NHS Foundation Trust
Newcastle upon Tyne, United Kingdom Recruiting -
Royal Gwent Hospital
Newport, United Kingdom Recruiting -
Nottingham University Hospitals NHS TRUST
Nottingham, United Kingdom Recruiting -
Queen Alexandra Hospital
Portsmouth, United Kingdom Recruiting -
Northern General Hospital
Sheffield, United Kingdom Recruiting -
University Hospital Southampton
Southampton, United Kingdom Recruiting -
South Tyneside and Sunderland NHS Foundation Trust
Sunderland, United Kingdom Recruiting -
Morriston Hospital
Swansea, United Kingdom Recruiting -
Pinderfields General Hospital
Wakefield, United Kingdom Recruiting -
New Cross Hospital
Wolverhampton, United Kingdom Recruiting -
Mater Private Hsopital
Cork, Ireland Completed -
Mater Private Hospital
Dublin, Ireland Completed -
Aberdeen Royal Hospital
Aberdeen, United Kingdom Completed -
Basildon University Hospital - Essex Cardiothoracic Centre
Basildon, United Kingdom Completed -
Royal Bournemouth Hospital
Bournemouth, United Kingdom Completed -
Royal Papworth Hospital NHS Foundation Trust
Cambridge, United Kingdom Active not recruiting -
NHS Greater Glasgow and Clyde
Glasgow, United Kingdom Not yet recruiting -
Barts Health NHS Trust - St. Bartholomew's Hospital
London, United Kingdom Active not recruiting -
Watford general Hospital
Watford, United Kingdom Completed
Study contacts
- Study coordinator: Colin Berry, MBChB, PhD
- Email: colin.berry@glasgow.ac.uk
- Phone: +44 141 330 3325
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating the usefulness of cardiovascular CT imaging for predicting outcomes
This study is trying to see if heart scans can help predict serious health issues and outcomes for patients with heart problems over a 10-year period.
-
Early LDL-C lowering with evolocumab after ACS to see if it slows plaque progression
This trial tests whether starting evolocumab soon after a heart attack or unstable angina, in addition to standard therapy, reduces non-culprit plaque growth over a year.
-
Women with chest pain and non-obstructive arteries: personalized diagnostic and treatment approach
This study tests a personalized diagnostic-and-treatment pathway for women with angina but non-obstructive coronary arteries to see if targeted therapy improves symptoms and quality of life.
-
Polish registry of heart nerve–targeting treatments (cardioneuroablation and cardioneuromodulation)
This registry collects information to see how nerve-targeting heart procedures work for adults with fainting, abnormal heart rhythms, or orthostatic problems.
-
Comprehensive coronary physiology testing for adults with angina but no blocked coronary arteries in the Czech Republic
This project will test detailed invasive coronary physiology and vasospasm tests in adults who have angina but no major coronary blockages to see if microvascular dysfunction or spasms explain their symptoms.
-
Personalized exercise and dietary program for patients with microvascular coronary dysfunction
This study is testing a personalized exercise and diet program to see if it helps people with microvascular coronary dysfunction feel better and manage their symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.